Neoplasia/BPH

	Correction to: Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry. Support Care Cancer Solberg A, Grydeland M, Nilsen TS, Storås AH, Davis ID, Greaves N, Anderson S, Fay AP, Chi KN, Enting D, McDermott R, Badal S, Waihenya CG, Popoola A, Lazarus JM, Mateo J, Bjartell A, Omlin A, Odedina F, Ragin C, Mucci LA, IRONMAN investigators, Russnes KM. PMID: 42825937 [PubMed - in process]
	Sexual and relational challenges in men and women affected by prostate cancer: a Project SEXUS study. BJU Int Lundorff IJ, Graugaard C, Fode M, Andersson M, Frisch M. PMID: 42825355 [PubMed - as supplied by publisher]
	Mechanisms of microbiome-immune interactions in bladder cancer and targeted regulatory strategies. Front Immunol Wu S, Fu S, Shi H, Gong Y, Chen P, Zhang X, Jiang E, Wang H. PMID: 42824830 [PubMed - indexed for MEDLINE]
	Reninoma in an adolescent boy with negative selective renal vein sampling: a case report and review of the literature. Front Endocrinol (Lausanne) Zhang L, Qiu D, Li J, Ma X, Xiao Y, Dong Z, Zhang Y, Zhu L, Xia Z, Lu W. PMID: 42824143 [PubMed - indexed for MEDLINE]
	Safety and functional efficacy of transperineal laser ablation in large prostates (>80 mL): a prospective single-center study. Minerva Urol Nephrol Conte FL, Saladino M, Lambertini L, Gajo L, Kucuku N, Conte F, Giustozzi B, Ferretti R, Posanzini S, Mazzola L, Salamone V, Carli G, Lipparini F, Leo F, Fahoum M, D'Ermo M, Carmona Garcia JJ, DI Maida F, Vittori G, Grosso AA, Minervini A, Mari A. PMID: 42823868 [PubMed - indexed for MEDLINE]
	Prostatic urethral lift in young men seeking preservation of ejaculatory function and fertility-related parameters: semen analysis up to 18 months and comparative review of MIST. Minerva Urol Nephrol D'Altilia N, Secco S, Guzzi F, Ricapito A, Finati M, Mazzotta L, Busetto GM, Bettocchi C, Carrieri G, Annese P. PMID: 42823867 [PubMed - indexed for MEDLINE]
	Importance of time to nephrectomy in localized renal cell cancer according to histological subtype. Minerva Urol Nephrol Filzmayer M, Polverino F, Petix M, Quarta L, Orlandi F, Goyal JA, Longo N, Musi G, Briganti A, Micali S, Shariat SF, Humke C, Traumann MI, Wenzel M, Saad F, Chun FK, Karakiewicz PI. PMID: 42823865 [PubMed - indexed for MEDLINE]
	CAIX-targeted PET/CT in clear cell renal cell carcinoma: a systematic review of current evidence and clinical perspectives. Minerva Urol Nephrol Garrou F, Sacchetti GM, Leva L, Manfredi M, DE Cillis S, Fiori C. PMID: 42823864 [PubMed - indexed for MEDLINE]
	Simultaneous surgery for NMIBC and BOO: evaluating surgical safety to oncological benefit. Minerva Urol Nephrol Ermi, Aybal HÇ, Yuan CY, Tozsin A, Fiori C, Herrmann T, Aydin A, Ahmed K, Güven S. PMID: 42823863 [PubMed - indexed for MEDLINE]
	Global guidelines for the management of penile cancer: evaluating clinical alignment and methodological rigor. Minerva Urol Nephrol Pandolfo SD, Aveta A, Iossa V, Cilio S, Palmieri A, Russo P, Lasorsa F, Lucarelli G, Siracusano S, Necchi A, Mercinelli C, Castiglione F, Manfredi C, Formisano L, Derweesh IH, Brouwer OR, Autorino R. PMID: 42823862 [PubMed - indexed for MEDLINE]
	Metastatic Bone Disease Is Associated With Longitudinal Muscle Loss and Reduced Survival in Kidney Cancer. J Cachexia Sarcopenia Muscle Poirier JL, Jines ST, Silverman LM, Kambrath AV, Wurtz LD, Zimmers TA, Collier CD. PMID: 42823780 [PubMed - indexed for MEDLINE]
	Refining prostate cancer diagnosis: correlative analysis of Gleason scores and immunohistochemical markers. Diagn Pathol Ao H, Liu Q. PMID: 42823706 [PubMed - indexed for MEDLINE]
	Surrogacy of intermediate clinical endpoints for overall survival in BCG-naÃ¯ve high-risk non-muscle-invasive bladder cancer. World J Urol Scilipoti P, , Subiela JD, Longoni M, Occhi A, Zaurito P, Tremolada G, Maiorano B, Soria F, Krajewski W, D'Andrea D, Claps F, Del Giudice F, Pichler R, Grobet-Jeandin E, Gallioli A, Afferi L, Mastroianni R, Simone G, Mertens LS, Laukhtina E, Rodriguez Elena JL, Aranda J, Lafuente Puentedura A, Caño Velasco J, Contieri R, Zorzi F, Liguori G, Hurle R, Cirulli GO, Naspro R, Mori K, Marcq G, Radziszewski P, Shariat SF, Gontero P, Rouprêt M, Seisen T, Montorsi F, Briganti A, Pradere B, Moschini M, European Association of Urology -Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. PMID: 42823574 [PubMed - indexed for MEDLINE]
	Circulating tumour DNA and extrachromosomal DNA in prostate and bladder cancer: biology, clinical applications and future perspectives. World J Urol Elmasmoudi J, Merseburger AS. PMID: 42823553 [PubMed - indexed for MEDLINE]
	Effect of Acupuncture on Urine Production and Storage in Prostate Cancer Survivors With Nocturia: Exploratory Analysis of a Randomized Clinical Trial. JU Open Plus Booher AG, Mao J, Sandhu J, Ajay D, Carlsson SV, Laudone V, Morris MJ, Liou KT. PMID: 42820187 [PubMed]
	Advances in Exosome Research in Renal Cell Carcinoma: Mechanisms, Biomarkers, and Therapeutic Applications. Int J Nanomedicine Luo J, Wang L, Zhou M, Huang W, Zhang M, He J, Yu B, Chen Z. PMID: 42820075 [PubMed - indexed for MEDLINE]
	Participation and satisfaction of prostate cancer patients on androgen deprivation therapy participating in a virtual supervised group exercise service. BJUI Compass Curtis E, Russell A, Cottrell C, Cowan-Dickie S, Dewhurst S, Kinsella N, Suh YE, Cahill D, Fox L, Van Hemelrijck M, Reid A. PMID: 42819773 [PubMed]
	Prognostic Impact of Diagnostic Delay in Testicular Cancer: A Single-center Mexican Cohort Study With Machine Learning Risk Prediction. Clin Genitourin Cancer Cantellano-Orozco M, Anceno A, Silva-Mendoza CA, Garzón-Ortega VH, Hosseini H, Angulo-Sánchez JR, Magdaleno-Rodríguez DR, Cervantes-Zorrilla R, Martínez-Arroyo C, Fernández-Noyola G, Morales-Montor G, Ortega-González M, Pacheco-Gahbler C. PMID: 42823227 [PubMed - as supplied by publisher]
	Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer. Eur Urol Davis LE, Basourakos SP, Calaway AC. PMID: 42823220 [PubMed - as supplied by publisher]
	Re: Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9Â yr Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. Eur Urol Gulati R, Etzioni R. PMID: 42823219 [PubMed - as supplied by publisher]

Articles 1 - 20 / 191767

Page 1 of 9589



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy